The earliest awards from the U.S. National Institutes of Health in support of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, totaling $46 million in fiscal 2014, have been disclosed. The funding goes to more than 100 investigators in 15 locations in the U.S. and three nations.
Device advice was in abundance at today's Food and Drug Law Institute panel discussion on the industry's compliance with promotion and advertising regs, featuring prominent industry lawyers from Medtronic, Covidien, Abbott and law firms.
Investors were pleased that TransEnterix scored a few more quarters' worth of runway in a $25 million debt deal, sending shares up almost 7% in early trading. The minimally invasive surgical company expects to submit a 510(k) for its SurgiBot by year end.
GlaxoSmithKline has disclosed its second deal in less than a week designed to improve the analysis of genetic mutations in oncology. The latest collaboration is with GE Healthcare to establish a network of clinical laboratories to identify genetic mutations associated with specific tumor types.
iHealth launched three mobile health apps on Apple's HealthKit and announced the integration of 9 medical devices onto HealthKit, all programmed to work in the new iOS8.
As devicemakers cast an eye toward a lucrative sleep disorder market, Itamar Medical is joining the ranks and anticipating positive third-quarter results buoyed by recent sales agreements and commercialization efforts for its sleep monitoring devices.
A study published Sept. 29 in The Journal of the American Medical Association concluded that publicly available information to support the safety and effectiveness of implanted, 510(k)-cleared devices is lacking.
Aerocrine has partnered with Microsoft in a pilot project to send data from nitric oxide monitoring devices to the cloud for analysis.
Engaged Capital has stepped up its campaign to wring shareholder value from Volcano after a stock slide of more than 60% in the last year. The firm made a detailed case against the company in an open letter to the company on Sept. 29. Engaged Capital has been openly targeting the intravascular imaging and device player since it took a sizable position more than a year ago.
Nightscout touts itself as an open source, do-it-yourself project to enable remote monitoring of blood glucose levels of patients with Type 1 diabetes.
Qardio recently launched QardioArm, its blood pressure monitoring and data collection app into App Store realm. QardioArm is the first medical device to initially integrate with Apple's HealthKit.
The FDA's powers to reclassify devices were restricted by a federal appeals court ruling that said the agency does not have the inherent authority to reclassify devices. Rather, the FDA must follow Congress' procedural requirements when reclassifying devices, including notice and comment procedures.
In light of new U.S. tax rules tightening the reins on corporate inversions, Medtronic could be poised to revise its $42.9 billion deal with Ireland-based Covidien.
Thanks to engineers at Oregon State University, people who have lost the use of their hands due to nerve trauma or a stroke might get their grip back with a simple pulley mechanism.
Leadless pacemakers are a "game-changing technology" that could eventually grab as much as 40% of the overall pacemaker market, say Leerink Swann equity analysts.
Investment group Blackstone has reportedly made a $100 million investment into Chinese orthopedic device company Xinrong Best Medical Instrument Co. This is the firm's first foray into a medical investment in China, but in March it did take private Chinese tech outsourcing company Pactera Technology.
A pair of contracts went to medical device makers from the U.S. Department of Defense on Sept. 23.
As the med tech industry casts its eye toward neurological implants that improve patient outcomes, researchers are developing a non-invasive technology that could protect against fatal complications by measuring blood flow in the brain.
A federal grand jury yesterday indicted James Mazzo--CEO of Santa Ana, CA-based Advanced Medical Optics from 2002 to 2009--on 13 counts of insider trading, 13 counts of tender offer fraud and one count of securities fraud, according to the U.S. Attorney's office.
Researchers have developed a new wearable medical device designed to continuously monitor tiny increments in temperature change on the skin's surface. It's only 5 centimeters square in size, worn directly on the skin and made of liquid photonic crystals on a flexible substrate.